ArticleOncoimmunology2022

Accumulation of dysfunctional tumor-infiltrating PD-1+ DCs links PD-1/PD-L1 blockade immunotherapeutic response in cervical cancer.

Yu-Meng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.